Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Hypogonadism × Gonadotropin-Releasing Hormone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3 Polycystic Ovary Syndrome 1 Metastatic Neuroendocrine Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Kallmann Syndrome 1 Hypogonadism 1 Hyperprolactinemia 1 Breast Neoplasms 1

Interventions

testosterone undecanoate 1 testosterone 17 beta-cypionate 1 Testosterone Propionate 1 Standard of Care 1 Practice Guidelines as Topic 1 Methyltestosterone 1 Gonadotropin-Releasing Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00914823 2024-07-31

Kisspeptin Administration in the Adult

Massachusetts General Hospital

Phase 1 Completed

Hyperprolactinemia, Hypogonadism, Polycystic Ovary Syndrome, Kallmann Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡